Preview

Problems of Endocrinology

Advanced search

Biological effects of thyroxine in experimental carcinogenesis

https://doi.org/10.14341/probl200551146-49

Abstract

The study was undertaken to examine the in vitro and in vivo effects ofthyroxine Т4 at the concentrations of 10ˉ4 M, 10ˉ6 M, 10ˉ M on the proliferative capacity and apoptosis of tumor cells of various pathogenesis. During the investigations, the authors used the unicellular suspension prepared from the surgical material obtained from 2 patients operated on for thyroid nodules (n = 1) and breast tumors in gynecomastia (n = 1) and evaluated the in vivo antitumor and antiproliferative activities of Т4, by using the melanoma B-16 inoculated in C57B1 mice. In the in vitro experiments, Т4 given in a dose of 10ˉ М produced the highest cytotoxic activity against benign thyroid tumor cells (70±4.58%; p < 0.05). When used in this dose, T4 induced the greatest apoptotic death of the cells (9.0±0.90%; p < 0.05) as compared with the controls (1.0±0.30%). The in vitro effect of T4 in doses of 10ˉ4 M, 10ˉ6 M, 10ˉ M on breast tumor cells in the presence of gynecomastia led to a decrease in levels of the oncogenic protein HER2/neu by an average of 27.25±1.14% (p < 0.001). In the in vivo experiments on a model of the tumor strain of melanoma B-16, T4 at the concentrations of 10ˉ4 M, 10ˉ6 M, 10ˉ M showed a high antitumor activity (59.00±5.54%; p < 0.001 of tumor growth suppression by mass and 74.12±0.26%; p < 0.001 by volume). When given in a dose of 10ˉ M, T4 displayed the highest antiproliferative activity (MI, 1.3±0.16%o, p < 0.001; AI, 10.65±1.39%, p < 0.001) as compared with the control group (MI, 4.96±0.43%o; AI, 4.43+0.40%).

About the Authors

A A Abduvaliyev

Institute of Biochemistry, Academy of Sciences of the Republic of Uzbekistan


Uzbekistan


M S Gildiyeva

Institute of Biochemistry, Academy of Sciences of the Republic of Uzbekistan


Uzbekistan


T S Saatov

Institute of Biochemistry, Academy of Sciences of the Republic of Uzbekistan


Uzbekistan


References

1. Герасимов Г.А. // Пробл. эндокринол. - 1996. - № 1. - С. 30-33.

2. Funahashi И., Imai Т., Tanaka Y. et al. // Jpn. J. Cancer Res. - 1999. - Vol.90. - P. 922-927.

3. John F.R. Kerr, Glenda C. Gobe, Clay M. Winterford et al. // Meth. Cell Biol. - 1995. - Vol.46. - P. 3-28.

4. Jorns A., Tiedge M., Lenzen S. // Diabetologia. - 2002. - Vol.45. - P. 851-855.

5. Klapper L.N., Kirschbaum M.H., Sela M. et al. // Adv. Cancer Res. - 2000. - Vol.77. - P. 25-79.

6. Kowalctyk P., Sielańczyk A., Nowak J. et al. // Pol. Arch. Med. Wewnet. - 2001. - Vol.105. - P. 123-130.

7. Lowe M.N., Plosker G.L. // Am. J. Clin. Dermatol. - 2000. - Vol.1. - P. 245-250.

8. Menon J., Wahrman M.Z. // In Vitro Cell Dev. Biol. Anim. - 2001. - Vol.37. - P. 283-292.

9. Monici M.C., Rodolico C., Toscano A. // Muscle Nerve. - 2002. - Vol.26. - P. 383-388.

10. Varas S.M., Muoz E.M., Hapon M.B. et al. // Reproduc-tion. - 2002. - Vol.124. - P. 691-702.


Review

For citations:


Abduvaliyev A.A., Gildiyeva M.S., Saatov T.S. Biological effects of thyroxine in experimental carcinogenesis. Problems of Endocrinology. 2005;51(1):46-49. (In Russ.) https://doi.org/10.14341/probl200551146-49

Views: 829


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)